Good morning and welcome to the Week Ahead at the start of a slightly quieter (and hopefully less bruising) week for private investors.
The first cut in interest rate from the Bank of England since 2020 (to 5% on Thursday) wasn’t enough to ease international investors’ concerns about the state of the US economy. Last week we saw disappointing jobs data, which sparked mutterings that the US Federal Reserve has left it too late to cut interest rates. As earnings season starts to come to an end, investors have started selling.
The S&P500 closed the week down more than 2%, with the FTSE All Share down 1.5%.
There is still a strong handful of financial results on both sides of the pond to take a look at this morning (see table for the full calendar). The pharmaceutical sector (always a hot industry in election year) has a few companies announcing numbers, which Megan will look at later. But for now, we’ve taken a look at two British companies which have been on a strong run.
Day | UK interim results | US quarterly results | EU quarterly results |
Monday - 5th August | Tyson Foods | Infineon Technologies | |
Tuesday - 6th August | InterContinental Hotels Group | Amgen | Zalando |
Wednesday - 7th August | Ibstock | CVS Health | Siemens |
Thursday - 8th August | Persimmon | Eli Lilly & Co | Allianz |
Friday - 9th August | Bellway | Bechtle |
Persimmon - On the road to recovery?
A few of the UK’s largest housebuilders will be providing updates next week. Roland Head recently wrote an excellent piece on the UK housing sector backdrop and what might come next for the housebuilders here. The article assesses the financial health and outlook of major UK housebuilders, noting that despite past profit surges, current valuations might still offer investment opportunities, especially if the sector's conditions improve as anticipated.
For now, however, we will focus…